<i>In vivo</i> phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
作者:Liming Shao、Una C. Campbell、Q. Kevin Fang、Noel A. Powell、John E. Campbell、Philip G. Jones、Taleen Hanania、Vadim Alexandrov、Irene Morganstern、Emily Sabath、Hua M. Zhong、Thomas H. Large、Kerry L. Spear
DOI:10.1039/c6md00128a
日期:——
A mouse-based assay (SmartCube) was used for both screening and lead optimization of a novel antipsychotic.
一种基于老鼠的检测方法(SmartCube)被用于一种新型抗精神病药物的筛选和首选优化。
Acridine Photocatalysis: Insights into the Mechanism and Development of a Dual-Catalytic Direct Decarboxylative Conjugate Addition
作者:Hang T. Dang、Graham C. Haug、Vu T. Nguyen、Ngan T. H. Vuong、Viet D. Nguyen、Hadi D. Arman、Oleg V. Larionov
DOI:10.1021/acscatal.0c03440
日期:2020.10.2
Conjugateaddition is one of the most synthetically useful carbon–carbon bond-forming reactions; however, reactive carbon nucleophiles are typically required to effect the addition. Radical conjugateaddition provides an avenue for replacing reactive nucleophiles with convenient radical precursors. Carboxylicacids can serve as simple and stable radical precursors by way of decarboxylation, but activation
[EN] HETEROCYCLIC AMIDES AS KINASE INHIBITORS<br/>[FR] AMIDES HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE KINASE
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2017109724A1
公开(公告)日:2017-06-29
Disclosed are compounds having the formula (I) wherein Q, X, A, L, B, Q4, R, RA, R5, n and m are as defined herein, and methods of making and using the same.
申请人:GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
公开号:US10961258B2
公开(公告)日:2021-03-30
Disclosed are compounds having Formula (I):
wherein Q, X, A, L, B, Q4, R, RA, R5, n and m are as defined herein, and methods of making and using the same.
公开了具有式 (I) 的化合物:
其中 Q、X、A、L、B、Q4、R、RA、R5、n 和 m 如本文所定义,以及制造和使用它们的方法。
Buu-Hoi et al., Recueil des Travaux Chimiques des Pays-Bas, 1950, vol. 69, p. 1053,1078